Apr 01, 2016 11:00 am UTC| Business
MENLO PARK, Calif., April 01, 2016 -- Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused biopharmaceutical company that is developing somavaratan (VRS-317), a novel, long-acting form of recombinant human growth hormone...
Manhattan Bridge Capital, Inc. Announces Payment of Quarterly $0.085 per Share Dividend
Apr 01, 2016 11:00 am UTC| Business
LONG ISLAND, N.Y., April 01, 2016 -- Manhattan Bridge Capital, Inc. (NASDAQ:LOAN) announced today that, in accordance with the board approved dividend declared on February 11, 2016, a cash dividend of $0.085 per share...
Apr 01, 2016 10:38 am UTC| Business
Dublin, April 01, 2016 -- Research and Markets has announced the addition of the "Global Nanocomposites Market Analysis Trends - Industry Forecast to 2025" report to their offering. ...
RR Donnelley to Announce First-Quarter Results and Host a Conference Call on May 3rd
Apr 01, 2016 10:30 am UTC| Business
CHICAGO, April 01, 2016 -- R.R. Donnelley Sons Company (NASDAQ:RRD) announced today that it will report first-quarter results and host a conference call on Tuesday, May 3, 2016. The conference call and live webcast...
Apr 01, 2016 10:29 am UTC| Business
Dublin, April 01, 2016 -- Research and Markets has announced the addition of the "Global Artificial Intelligence Market Analysis Trends - Industry Forecast to 2025" report to their offering. ...
Apr 01, 2016 10:00 am UTC| Business
VERO BEACH, Florida, April 01, 2016 -- ARMOUR Residential REIT, Inc. (NYSE: ARR, ARR PrA and ARR PrB) (“ARMOUR”) and JAVELIN Mortgage Investment Corp. (NYSE:JMI) (“JAVELIN”) today announced that the Circuit Court for...
Mesoblast Cell Therapy Shows Disease Modifying Effects on Knee Osteoarthritis
Apr 01, 2016 10:00 am UTC| Business
NEW YORK and MELBOURNE, Australia, April 01, 2016 -- Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced that results from its Phase 2a trialin patients with post-traumatic knee injury to the anterior cruciate...